Future of Novel Therapies in the Management of Relapsed and Refractory Multiple Myeloma
Dana-Farber Cancer Institute via YouTube
Learn Backend Development Part-Time, Online
Build AI Apps with Azure, Copilot, and Generative AI — Microsoft Certified
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
In this 26-minute video, Dr. Paul Richardson from Dana-Farber Cancer Institute offers a clinical perspective on emerging treatment approaches for patients with relapsed/refractory multiple myeloma. Gain insights into innovative therapies that show promise for improving outcomes in this challenging disease setting. Explore the evolving landscape of multiple myeloma management, including new drug combinations, immunotherapies, and targeted approaches that are reshaping treatment paradigms for patients who have experienced disease progression after initial therapy.
Syllabus
Future of Novel Therapies in the Management of Relapsed and Refractory Multiple Myeloma
Taught by
Dana-Farber Cancer Institute